Sustained In-Vivo Release of Triptorelin Acetate from a Biodegradable Silica Depot: Comparison to Pamorelin® LA
Open Access
- 16 June 2021
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 11 (6), 1578
- https://doi.org/10.3390/nano11061578
Abstract
Triptorelin acetate was encapsulated into silica microparticles by spray-drying a mixture of colloidal silica sol and triptorelin acetate solution. The resulting microparticles were then combined with another silica sol containing silica nanoparticles, which together formed an injectable silica-triptorelin acetate depot. The particle size and surface morphology of the silica-triptorelin acetate microparticles were characterized together with the in vitro release of triptorelin, injectability and rheology of the final injectable silica-triptorelin acetate depot. In vivo pharmacokinetics and pharmacodynamics of the silica-triptorelin acetate depot and Pamorelin® were evaluated and compared in Sprague-Dawley male rats after subcutaneous administration. Serum samples up to 91 days were collected and the plasma concentrations of triptorelin and testosterone were analyzed with ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). In vivo pharmacokinetics showed that injections of the silica-triptorelin acetate depot gave 5-fold lower Cmax values than the corresponding Pamorelin® injections. The depot also showed a comparable sustained triptorelin release and equivalent pharmacodynamic effect as the Pamorelin® injections. Detectable triptorelin plasma concentrations were seen with the depot after the 91-day study period and testosterone plasma concentrations remained below the human castration limit for the same period.Keywords
This publication has 26 references indexed in Scilit:
- 2018 Update on Intravitreal Injections: Euretina Expert Consensus RecommendationsOphthalmologica, 2018
- Anti-angiogenesis through noninvasive to minimally invasive intraocular delivery of the peptide CC12 identified by in vivo-directed evolutionBiomaterials, 2017
- PLA micro- and nano-particlesAdvanced Drug Delivery Reviews, 2016
- The Sol–Gel Route to Advanced Silica-Based Materials and Recent ApplicationsChemical Reviews, 2013
- Bioceramics for drug deliveryActa Materialia, 2013
- Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities & challengesNanoscale, 2010
- Rationale of Using Conventional Sol-Gel Derived SiO2 for Delivery of Biologically Active AgentsKey Engineering Materials, 2008
- Does Needle Size Matter?Journal of Diabetes Science and Technology, 2007
- Adjustably Bioresorbable Sol-Gel Derived SiO2 Matrices for Release of Large Biologically Active MoleculesJournal of Sol-Gel Science and Technology, 2005
- Chemical characterization of bioresorbable sol–gel derived SiO2 matrices prepared at protein-compatible pHJournal of Non-Crystalline Solids, 2005